Details

The importance of sex dimorphism in liver metabolism and progressive liver diseases
ID Kočar, Eva (Author), ID Blagotinšek Cokan, Kaja (Author), ID Kreft, Tinkara (Author), ID Režen, Tadeja (Author), ID Rozman, Damjana (Author)

.pdfPDF - Presentation file, Download (2,29 MB)
MD5: A5D01CDE87ACB14C95DAFA7C0045808E
URLURL - Source URL, Visit https://link.springer.com/article/10.1186/s13293-025-00811-7 This link opens in a new window

Abstract
The liver is a central metabolic organ with pronounced sex-specific differences shaped by sex hormones, sex chromosome-linked gene expression, ageing, and circadian rhythm. These factors influence disease susceptibility, progression, and treatment response, with notable differences between females and males in the prevalence, severity, and clinical outcomes of metabolic dysfunction-associated steatotic liver disease. This condition represents a growing global health burden that can progress to hepatocellular carcinoma, the second leading cause of cancer-related death worldwide. Despite this impact, sex remains an underexplored variable in liver research, and the molecular mechanisms by which sex influences disease development remain poorly understood. In this review, we examine the key determinants of sex differences in liver pathogenesis. We highlight the protective role of estrogen signaling in female liver metabolism, the increased vulnerability to disease progression after menopause, and the contribution of circadian regulation to sex-specific outcomes. We further discuss how the lack of systematic inclusion of both sexes in preclinical and clinical studies limits the identification of biomarkers and the development of effective therapeutic interventions. Incorporating sex as a biological variable is therefore essential to improve mechanistic understanding, translational relevance, and the personalization of treatment approaches. Particular emphasis is placed on animal models that reflect sex-specific liver physiology and pathophysiology, as these provide valuable frameworks for studying disease progression and testing targeted interventions. In summary, recognizing and integrating sexual dimorphism in liver metabolism is crucial to advancing prevention, diagnosis, and treatment strategies. Addressing sex differences is critical for developing accurate diagnostic tools and personalized therapeutic approaches, ultimately improving outcomes for both women and men with liver disease.

Language:English
Keywords:animal models, fibrosis, HCC, liver, MASH, MASLD, sexual dimorphism
Work type:Article
Typology:1.02 - Review Article
Organization:MF - Faculty of Medicine
Publication status:Published
Publication version:Version of Record
Year:2026
Number of pages:20 str.
Numbering:Vol. 17, iss. 1, art. 14
PID:20.500.12556/RUL-179367 This link opens in a new window
UDC:577.2
ISSN on article:2042-6410
DOI:10.1186/s13293-025-00811-7 This link opens in a new window
COBISS.SI-ID:267517699 This link opens in a new window
Publication date in RUL:12.02.2026
Views:341
Downloads:232
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Biology of sex differences
Shortened title:Biol. sex differ.
Publisher:Springer Nature
ISSN:2042-6410
COBISS.SI-ID:518176025 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:živalski modeli, fibroza, jetra, spolni dimorfizem

Projects

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P1-0104
Name:Funkcijska genomika in biotehnologija za zdravje

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P1-0390
Name:Funkcijska genomika in biotehnologija za zdravje

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J3-4513
Name:Vloga in aplikativnost krožnih RNA pri raku jeter

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J1-9176
Name:HolesteROR pri presnovnih boleznih jeter

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J1-50024
Name:Povezava med hipoksijo in sintezo holesterola v cirkadianem času

Funder:ARIS - Slovenian Research and Innovation Agency
Name:ELIXIR-SI RI-SI-2

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back